Don Jung

459 total citations
9 papers, 255 citations indexed

About

Don Jung is a scholar working on Cancer Research, Cell Biology and Oncology. According to data from OpenAlex, Don Jung has authored 9 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 3 papers in Cell Biology and 2 papers in Oncology. Recurrent topics in Don Jung's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (2 papers) and Aldose Reductase and Taurine (2 papers). Don Jung is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (2 papers) and Aldose Reductase and Taurine (2 papers). Don Jung collaborates with scholars based in United States, Germany and China. Don Jung's co-authors include Charles P. Hart, Mark Matteucci, Monica Banica, Timothy F. Stanton, W. S. Ammons, Robert M. Hoffman, Jinwei Wang, Huaiyu Ma, Jacob A. Kaizerman and Zhijian Yang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Don Jung

8 papers receiving 238 citations

Peers

Don Jung
Comparison fields: 5 of 61
  • Cancer Research 147
  • Molecular Biology 111
  • Oncology 65
  • Biomedical Engineering 44
  • Pulmonary and Respiratory Medicine 42
Replace Gillian Hutchison with:
Gillian Hutchison United Kingdom
Luca Pompili Italy
C. Widakowich Belgium
R. Faissner Germany
E. Boven Netherlands
Giulia Brisotto Italy
René Delosh United States
James T. Topham Canada
Julie Laudeman United States
Yanbo Zheng China
Gillian Hutchison United Kingdom View profile →
Citations per field, relative to Don Jung
Don Jung · 1×
Citations per year, relative to Don Jung
Don Jung · 1×

Countries citing papers authored by Don Jung

Since Specialization
Citations

This map shows the geographic impact of Don Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Jung more than expected).

Fields of papers citing papers by Don Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Jung. The network helps show where Don Jung may publish in the future.

Co-authorship network of co-authors of Don Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Don Jung. A scholar is included among the top collaborators of Don Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don Jung. Don Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 1
2 3
3 21
4 1
5 1
6 188
7 4
8
Phase I trial of glycolitic inhibition with 2-deoxyglucose and docetaxel for patients with solid tumors
4
9 32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026